Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 24207854 JOHN WILEY & SONS A/S (fortsættende), der tillige driver virksomhed under navnene MUNKSGAARDS FORLAG A/S, MUNKSGAARD A/S, ACTA NEUROLOGICA SCANDINAVICA A/S, ACTA PSYCHIATRICA SCANDINAVICA A/S, ALLERGY A/S, AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY A/S, CLINICAL GENETICS A/S, CLINICAL ORAL IMPLANTS RESEARCH A/S, CLINICAL TRANSPLANTATION A/S, COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY A/S, CONTACT DERMATITIS A/S, ECOLOGY OF FRESHWATER FISH A/S, ENDODONTICS & DENTAL TRAUMATOLOGY A/S, EUROPEAN JOURNAL OF HAEMATOLOGY A/S, EUROPEAN JOURNAL OF ORAL SCIENCES A/S, EXPERIMENTAL DERMATOLOGY A/S, IMMUNOLOGIVAL REVIEWS A/S, INDOOR AIR A/S, INTERNATIONAL JOURNAL OF PEPTIDE & PROTEIN RESEARCH A/S, JOURNAL OF CLINICAL PERIODONTOLOGY A/S, JOURNAL OF CUTANEOUS PATHOLOGY A/S, JOURNAL OF MEDICAL PRIMATOLOGY A/S, JOURNAL OF ORAL PATHOLOGY & MEDICINE A/S, JOURNAL OF PERIODONTAL RESEARCH A/S, JOURNAL OF PINEAL RESEARCH A/S, LIVER A/S, ORAL MICROBIOLOGY AND IMMUNOLOGY A/S, PEDIATRIC ALLERGY AND IMMUNOLOGY A/S, PERIODONTOLOGY 2000 A/S, PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE A/S, PIGMENT CELL RESEARCH A/S, SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS A/S, SKIN RESEARCH AND TECHNOLOGY A/S, TISSUE ANTIGENS A/S, XENOTRANSPLANTATION A/S, BLACKWELL MUNKSGAARD A/S, WILEY-BLACKWELL A/S, CVR-nummer: 26931037 WILEY ApS (ophørende), der tillige driver virksomhed under navnene INSCAPE PARTNERS INTERNATIONAL ApS og CVR-nummer: 19961249 DISCOVER A/S (ophørende), der tillige driver virksomhed under navnene INSCAPE PARTNERS COPENHAGEN A/S. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 24207854 JOHN WILEY & SONS A/S, CVR-nummer: 26931037 WILEY ApS og CVR-nummer: 19961249 DISCOVER A/S må antages at være tilstrækkeligt sikrede efter fusionen.